JP2017511322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511322A5 JP2017511322A5 JP2016559891A JP2016559891A JP2017511322A5 JP 2017511322 A5 JP2017511322 A5 JP 2017511322A5 JP 2016559891 A JP2016559891 A JP 2016559891A JP 2016559891 A JP2016559891 A JP 2016559891A JP 2017511322 A5 JP2017511322 A5 JP 2017511322A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- moiety
- soluble polymer
- water
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461974914P | 2014-04-03 | 2014-04-03 | |
| US61/974,914 | 2014-04-03 | ||
| PCT/US2015/023871 WO2015153753A2 (en) | 2014-04-03 | 2015-04-01 | Conjugates of an il-15 moiety and a polymer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020074680A Division JP2020114875A (ja) | 2014-04-03 | 2020-04-20 | Ｉｌ−１５部分とポリマーとのコンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511322A JP2017511322A (ja) | 2017-04-20 |
| JP2017511322A5 true JP2017511322A5 (enExample) | 2018-04-12 |
| JP6728055B2 JP6728055B2 (ja) | 2020-07-22 |
Family
ID=54241432
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016559891A Active JP6728055B2 (ja) | 2014-04-03 | 2015-04-01 | Ｉｌ−１５部分とポリマーとのコンジュゲート |
| JP2020074680A Withdrawn JP2020114875A (ja) | 2014-04-03 | 2020-04-20 | Ｉｌ−１５部分とポリマーとのコンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020074680A Withdrawn JP2020114875A (ja) | 2014-04-03 | 2020-04-20 | Ｉｌ−１５部分とポリマーとのコンジュゲート |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170035898A1 (enExample) |
| EP (2) | EP3919071A1 (enExample) |
| JP (2) | JP6728055B2 (enExample) |
| KR (1) | KR102432169B1 (enExample) |
| CN (1) | CN106456716A (enExample) |
| AU (3) | AU2015240806B2 (enExample) |
| CA (1) | CA2942571C (enExample) |
| ES (1) | ES2876433T3 (enExample) |
| IL (1) | IL248169A0 (enExample) |
| MA (1) | MA39711A (enExample) |
| MX (2) | MX388865B (enExample) |
| WO (1) | WO2015153753A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015014438A (es) | 2013-04-18 | 2016-05-18 | Armo Biosciences Inc | Metodos de uso de interleucina-10 para tratar enfermedades y trastornos. |
| EP3010527B1 (en) | 2013-06-17 | 2018-08-08 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
| CN105658232A (zh) | 2013-08-30 | 2016-06-08 | 阿尔莫生物科技股份有限公司 | 使用白细胞介素-10治疗疾病和病症的方法 |
| CN120242030A (zh) | 2013-11-11 | 2025-07-04 | 阿尔莫生物科技股份有限公司 | 将白细胞介素-10用于治疗疾病和病症的方法 |
| WO2015187295A2 (en) | 2014-06-02 | 2015-12-10 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
| WO2016060996A2 (en) | 2014-10-14 | 2016-04-21 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
| AU2015336101A1 (en) | 2014-10-22 | 2017-04-20 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| WO2016126615A1 (en) | 2015-02-03 | 2016-08-11 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| US20160361415A1 (en) | 2015-05-28 | 2016-12-15 | Armo Biosciences, Inc. | Methods of Using Interleukin-10 for Treating Diseases and Disorders |
| KR20180038553A (ko) | 2015-08-25 | 2018-04-16 | 아르모 바이오사이언시스 인코포레이티드 | 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법 |
| WO2017062832A1 (en) | 2015-10-08 | 2017-04-13 | Nektar Therapeutics | Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist |
| MX2018007304A (es) * | 2015-12-21 | 2019-03-14 | Armo Biosciences Inc | Composiciones de interleucina-15 y sus usos. |
| CN109715196A (zh) | 2016-06-13 | 2019-05-03 | 转矩医疗股份有限公司 | 用于促进免疫细胞功能的组合物和方法 |
| IL270634B2 (en) * | 2017-05-15 | 2025-06-01 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
| CA3074826A1 (en) | 2017-09-05 | 2019-03-14 | Torque Therapeutics, Inc. | Therapeutic protein compositions and methods of making and using the same |
| CN112004547A (zh) | 2018-02-26 | 2020-11-27 | 新索思股份有限公司 | Il-15缀合物及其用途 |
| WO2020097556A1 (en) * | 2018-11-09 | 2020-05-14 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonist in combination with another pharmacologically active agent |
| CN114126638A (zh) * | 2019-04-26 | 2022-03-01 | 普罗林科斯有限责任公司 | 缓慢释放的细胞因子偶联物 |
| US11248025B2 (en) | 2019-06-03 | 2022-02-15 | Medikine, Inc. | IL-2alpha receptor subunit binding compounds |
| EP4017540A1 (en) * | 2019-08-23 | 2022-06-29 | Synthorx, Inc. | Il-15 conjugates and uses thereof |
| JP2024512761A (ja) * | 2021-03-29 | 2024-03-19 | オーディー セラピューティクス リミテッド | タンパク質－高分子コンジュゲートおよびその使用方法 |
| CN117597355A (zh) | 2021-06-23 | 2024-02-23 | 赛腾制药 | 白细胞介素15变体 |
| EP4370536A4 (en) * | 2021-07-12 | 2026-04-22 | Nektar Therapeutics | MODIFIED POLYMER FORMS OF INTERFERON-GAMMA AND METHODS OF USE |
| EP4463135A2 (en) | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| WO2025101551A1 (en) * | 2023-11-06 | 2025-05-15 | Regents Of The University Of Minnesota | Prostate-specific membrane antigen (psma)-binding peptides and method of use |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166322A (en) | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| AU1096595A (en) * | 1993-11-12 | 1995-05-29 | Gilead Sciences, Inc. | Thrombin mutants |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| WO1995027722A1 (en) | 1994-04-06 | 1995-10-19 | Immunex Corporation | Interleukin-15 |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5795966A (en) | 1995-02-22 | 1998-08-18 | Immunex Corp | Antagonists of interleukin-15 |
| US7008624B1 (en) * | 1995-02-22 | 2006-03-07 | Immunex Corporation | Antagonists of interleukin-15 |
| JP4078032B2 (ja) | 1998-03-12 | 2008-04-23 | ネクター セラピューティックス エイエル，コーポレイション | 近位の反応性基を持つポリ（エチレングリコール）誘導体 |
| US6602498B2 (en) | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
| MXPA05007151A (es) * | 2002-12-31 | 2005-09-21 | Nektar Therapeutics Al Corp | Polimeros terminados en maleimida hidroliticamente estables. |
| KR101207247B1 (ko) | 2003-01-06 | 2012-12-03 | 넥타르 테라퓨틱스 | 티올-선택성 수용성 중합체 유도체 |
| EP1670501A2 (en) * | 2003-09-25 | 2006-06-21 | ZymoGenetics, Inc. | Methods of treating autoimmune diseases using il-21 |
| TW200613552A (en) * | 2004-08-11 | 2006-05-01 | Hoffmann La Roche | Mutant interleukin-15 polypeptides |
| JP2008515896A (ja) | 2004-10-05 | 2008-05-15 | オクスナー クリニック ファウンデーション | Ｉｌ−１５によるｂ細胞増殖の増強 |
| US20060257361A1 (en) * | 2005-04-12 | 2006-11-16 | Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services | Novel form of interleukin-15, Fc-IL-15, and methods of use |
| HUE025208T2 (en) | 2005-06-16 | 2016-03-29 | Nektar Therapeutics | Conjugates with degradable binding and polymer reagents useful in the preparation of such conjugates |
| EP2134181A4 (en) | 2007-02-28 | 2011-09-28 | Serina Therapeutics Inc | ACTIVATED POLYOXAZOLINES AND COMPOSITION COMPRISING THE SAME |
| PL2431741T3 (pl) * | 2008-10-21 | 2014-01-31 | Baxalta Inc | Sposoby określania ilości aktywnych składników w prolekach, będących koniugatami PEG-białko, za pomocą reagentów uwalniających PEG (depegylacja in vitro) |
| TR201908836T4 (tr) * | 2010-07-30 | 2019-07-22 | Baxalta GmbH | Oksim bağına yönelik nükleofilik katalizörler. |
| WO2012065086A1 (en) * | 2010-11-12 | 2012-05-18 | Nektar Therapeutics | Conjugates of an il-2 moiety and a polymer |
| CN102145178B (zh) * | 2011-04-15 | 2012-09-26 | 北京凯因科技股份有限公司 | Peg化白介素15 |
| WO2013020079A2 (en) * | 2011-08-04 | 2013-02-07 | Nektar Therapeutics | Conjugates of an il-11 moiety and a polymer |
-
2015
- 2015-03-31 MA MA039711A patent/MA39711A/fr unknown
- 2015-04-01 US US15/301,681 patent/US20170035898A1/en not_active Abandoned
- 2015-04-01 MX MX2016012908A patent/MX388865B/es unknown
- 2015-04-01 KR KR1020167027127A patent/KR102432169B1/ko active Active
- 2015-04-01 JP JP2016559891A patent/JP6728055B2/ja active Active
- 2015-04-01 EP EP21169371.8A patent/EP3919071A1/en active Pending
- 2015-04-01 CN CN201580017361.XA patent/CN106456716A/zh active Pending
- 2015-04-01 WO PCT/US2015/023871 patent/WO2015153753A2/en not_active Ceased
- 2015-04-01 CA CA2942571A patent/CA2942571C/en active Active
- 2015-04-01 EP EP15773976.4A patent/EP3139947B8/en active Active
- 2015-04-01 ES ES15773976T patent/ES2876433T3/es active Active
- 2015-04-01 AU AU2015240806A patent/AU2015240806B2/en active Active
-
2016
- 2016-09-30 MX MX2021015492A patent/MX2021015492A/es unknown
- 2016-10-02 IL IL248169A patent/IL248169A0/en active IP Right Grant
-
2019
- 2019-12-16 AU AU2019283778A patent/AU2019283778A1/en not_active Abandoned
-
2020
- 2020-04-20 JP JP2020074680A patent/JP2020114875A/ja not_active Withdrawn
-
2021
- 2021-10-28 AU AU2021258008A patent/AU2021258008A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017511322A5 (enExample) | ||
| JP2018510863A5 (enExample) | ||
| HRP20210642T1 (hr) | Konjugati il-2 ostatka i polimera | |
| JP2006519238A5 (enExample) | ||
| Birke et al. | Polypeptoid-block-polypeptide copolymers: Synthesis, characterization, and application of amphiphilic block copolypept (o) ides in drug formulations and miniemulsion techniques | |
| WO2009021017A3 (en) | Nucleic acid-lipopolymer compositions | |
| Kloeckner et al. | Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties | |
| WO2011079279A3 (en) | Nanoconjugates and nanoconjugate formulations | |
| EP3549963A3 (en) | High molecular weight zwitterion-containing polymers | |
| WO2011112482A3 (en) | Polymeric drug delivery conjugates and methods of making and using thereof | |
| Heller et al. | Directed Interactions of Block Copolypept (o) ides with Mannose‐binding Receptors: PeptoMicelles Targeted to Cells of the Innate Immune System | |
| Abebe et al. | Three‐layered biodegradable micelles prepared by two‐step self‐assembly of PLA‐PEI‐PLA and PLA‐PEG‐PLA triblock copolymers as efficient gene delivery system | |
| JP2011530597A5 (enExample) | ||
| Cunningham et al. | New Design of Thiol‐Responsive Degradable Polylactide‐Based Block Copolymer Micelles | |
| JP2011080089A5 (enExample) | ||
| JP2005520006A5 (enExample) | ||
| JP2013519636A5 (enExample) | ||
| ES2721850T3 (es) | Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas | |
| WO2010005740A3 (en) | Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles | |
| WO2012054923A3 (en) | Therapeutic nanoparticles with high molecular weight copolymers | |
| JP2014058562A5 (enExample) | ||
| ATE477291T1 (de) | Präparate umfassend hyperverzweigte polymere | |
| JP2019512006A5 (enExample) | ||
| JP2014503548A5 (enExample) | ||
| MX2013012934A (es) | Nanoparticulas polimericas para el suministro de farmacos. |